http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007113900-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
filingDate | 2005-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2008-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2007113900-A |
titleOfInvention | IMIDAZOCHINOLINE COMPOUNDS |
abstract | 1. The compound of formula (I): where R is —NRR, —C (O) R, —C (O) OR, —C (O) NRR, - (CH) CH = CH (CH) R, - (CH ) C≡C (CH) R or -S (O) R; R is H, C1-6 alkyl, substituted C1-6 alkyl, - (CH) CH = CH (CH) R, - (CH) C≡C (CH) R, -C (O) R, —C (O) OR, —C (O) NRR, or —S (O) R; each R is independently H, C 1-6 alkyl, substituted C 1-6 alkyl, C 1 alkoxy, halogen, trihalomethyl, —NRR, —C (O) R, —C (O) OR, or —C (O) NRR; each of R and R independently represents H, C1-6alkyl, Saryl-Calkyl or a protecting group; each of R and R independently represents H, C1-6alkyl, substituted C1-6alkyl, Calkoxy, Calkoxy-Calkyl , Saryl, Saryl-C1-6alkyl, Saryloxy-C1-6alkyl, - (CH) CH = CH (CH) R or - (CH) C≡C (CH) R; or R and R, together taken, form a substituted or unsubstituted heterocyclyl group; each R independently represents H, C1-6alkyl or substituted C1-6alkyl; each R independently represents H, C1-6alkyl, substituted C1-6alkyl, Salkenyl, Saryl, —COH, —C (O) O — C1-6alkyl or halogen; each R independently is C1-6alkyl, substituted C1-6alkyl, Salkenyl, Saryl, Saryl-C1-6alkyl, trihalomethyl or —NRR; each of m and n is independently 0, 1, 2 or 3; p is 0, 1, 2 or 3; and each q is independently 0, 1, or 2; or a pharmaceutically acceptable salt, a tautomer thereof, or a pharmaceutically acceptable salt of a tautomer; provided that if R is —S — Me, then R is not isobutyl. 2. The compound according to claim 1, in which each of R and R represents H.3. A compound according to claim 2, in which R is —NRR. 4. A compound according to claim 2, wherein R is —S (O) R.5. A compound according to claim 2, wherein R is —C (O) NRR. 6. A compound according to claim 2, in which R is - (CH) CH = CH (CH) R. 7. The compound according to claim 2, in which R is - (CH) C (C (CH) R. 8. A compound according to any one of claims 1 to 7, wherein R1 is C1-6alkyl. The compound according to claim 3, in which R and Rin R� |
priorityDate | 2004-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 259.